Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR

Rang în acțiuni #36458
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
Preț acțiune
$1.73
Ultima sincronizare: 2025-06-17
Capitalizare de piață
$2.55M
Schimbare (1 zi)
-0.29%
Schimbare (1 an)
-79.71%
Țară
US
Tranzacționează Eiger BioPharmaceuticals, Inc. (EIGR)

Categorie

Healthcare
Raport P/S pentru Eiger BioPharmaceuticals, Inc. (EIGR)
Raport P/S la data de October 2026 TTM: 0.80
Conform celor mai recente rapoarte financiare și prețului acțiunilor Eiger BioPharmaceuticals, Inc., raportul P/S actual (TTM) este 0.80. La sfârșitul anului 2022, compania avea un P/S de 3.64.
Istoricul raportului P/S pentru Eiger BioPharmaceuticals, Inc. din 2016 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
2026 (TTM) 0.80 20.91%
2023 0.66 -81.89%
2022 3.64 -74.89%
2021 14.51 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.02 1,155.90%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
40.55 4,981.55%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.96 396.38%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.15 1,171.47%
NL